P787: SABATOLIMAB (MBG453) COMBINATION TREATMENT REGIMENS FOR PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES: THE MYELODYSPLASTIC SYNDROMES STUDIES IN THE STIMULUS IMMUNO-MYELOID CLINICAL TRIAL PROGRAM

Bibliographic Details
Main Authors:	A. M. Zeidan, A. Al-Kali, U. Borate, T. Cluzeau, A. E. DeZern, J. Esteve, A. Giagounidis, K. Kobata, R. Lyons, U. Platzbecker, D. A. Sallman, V. Santini, G. F. Sanz, M. A. Sekeres, A. H. Wei, Z. Xiao, M. Van Hoef, C. Nourry-Boulot, I. Sadek, F. Ma, A. Iordan, J. Sabo, G. Garcia-Manero
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000846032.37876.c9

Internet